» Articles » PMID: 38346942

Kisspeptin-10 Binding to Gpr54 in Osteoclasts Prevents Bone Loss by Activating Dusp18-mediated Dephosphorylation of Src

Abstract

Osteoclasts are over-activated as we age, which results in bone loss. Src deficiency in mice leads to severe osteopetrosis due to a functional defect in osteoclasts, indicating that Src function is essential in osteoclasts. G-protein-coupled receptors (GPCRs) are the targets for ∼35% of approved drugs but it is still unclear how GPCRs regulate Src kinase activity. Here, we reveal that GPR54 activation by its natural ligand Kisspeptin-10 (Kp-10) causes Dusp18 to dephosphorylate Src at Tyr 416. Mechanistically, Gpr54 recruits both active Src and the Dusp18 phosphatase at its proline/arginine-rich motif in its C terminus. We show that Kp-10 binding to Gpr54 leads to the up-regulation of Dusp18. Kiss1, Gpr54 and Dusp18 knockout mice all exhibit osteoclast hyperactivation and bone loss, and Kp-10 abrogated bone loss by suppressing osteoclast activity in vivo. Therefore, Kp-10/Gpr54 is a promising therapeutic target to abrogate bone resorption by Dusp18-mediated Src dephosphorylation.

Citing Articles

Application of integrated omics in aseptic loosening of prostheses after hip replacement.

Liu Y, Dong Y, Liang X, Qiang S, Li M, Sun Z Mol Med Rep. 2025; 31(3.

PMID: 39749710 PMC: 11726296. DOI: 10.3892/mmr.2025.13430.


Beyond resorption: osteoclasts as drivers of bone formation.

Xiang Q, Li L, Ji W, Gawlitta D, Walboomers X, van den Beucken J Cell Regen. 2024; 13(1):22.

PMID: 39392536 PMC: 11469995. DOI: 10.1186/s13619-024-00205-x.

References
1.
Civciristov S, Ellisdon A, Suderman R, Pon C, Evans B, Kleifeld O . Preassembled GPCR signaling complexes mediate distinct cellular responses to ultralow ligand concentrations. Sci Signal. 2018; 11(551). PMC: 7416780. DOI: 10.1126/scisignal.aan1188. View

2.
Son H, Kim K, Kim E, Jang W . Kisspeptin-10 (KP-10) stimulates osteoblast differentiation through GPR54-mediated regulation of BMP2 expression and activation. Sci Rep. 2018; 8(1):2134. PMC: 5794871. DOI: 10.1038/s41598-018-20571-2. View

3.
Destaing O, Sanjay A, Itzstein C, Horne W, Toomre D, De Camilli P . The tyrosine kinase activity of c-Src regulates actin dynamics and organization of podosomes in osteoclasts. Mol Biol Cell. 2007; 19(1):394-404. PMC: 2174183. DOI: 10.1091/mbc.e07-03-0227. View

4.
Heckel T, Czupalla C, Expirto Santo A, Anitei M, Sanchez-Fernandez M, Mosch K . Src-dependent repression of ARF6 is required to maintain podosome-rich sealing zones in bone-digesting osteoclasts. Proc Natl Acad Sci U S A. 2009; 106(5):1451-6. PMC: 2635769. DOI: 10.1073/pnas.0804464106. View

5.
Hannon R, Clack G, Rimmer M, Swaisland A, Lockton J, Finkelman R . Effects of the Src kinase inhibitor saracatinib (AZD0530) on bone turnover in healthy men: a randomized, double-blind, placebo-controlled, multiple-ascending-dose phase I trial. J Bone Miner Res. 2009; 25(3):463-71. DOI: 10.1359/jbmr.090830. View